Targeted colonic release formulations of mesalazine – A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted colonic release formulations of mesalazine – A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 625, Issue -, Pages 122055
Publisher
Elsevier BV
Online
2022-08-01
DOI
10.1016/j.ijpharm.2022.122055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colonic delivery of metronidazole-loaded capsules for local treatment of bacterial infections: A clinical pharmacoscintigraphy study
- (2021) Daniel Preisig et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
- (2021) Tim Raine et al. Journal of Crohns & Colitis
- OPTICORE™, an innovative and accurate colonic targeting technology
- (2020) Felipe Varum et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A dual pH and microbiota-triggered coating (Phloral™) for fail-safe colonic drug release
- (2020) Felipe Varum et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In vitro and human pharmacoscintigraphic evaluation of an oral 5-ASA delivery system for colonic release
- (2019) Anastasia Foppoli et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance
- (2018) Grace B. Hatton et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose
- (2018) Jessica R. Allegretti et al. DIGESTIVE DISEASES AND SCIENCES
- American Gastroenterological Association Institute Guideline on the Management of Mild-to-Moderate Ulcerative Colitis
- (2018) Cynthia W. Ko et al. GASTROENTEROLOGY
- Targeted delivery of probiotics to enhance gastrointestinal stability and intestinal colonisation
- (2017) Cornelius C. Dodoo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Assessment of Small Intestinal Transit Times in Ulcerative Colitis and Crohn’s Disease Patients with Different Disease Activity Using Video Capsule Endoscopy
- (2016) Monika Fischer et al. AAPS PHARMSCITECH
- Regional gastrointestinal transit times in severe ulcerative colitis
- (2016) A. M. Haase et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Gastrointestinal release behaviour of modified-release drug products: Dynamic dissolution testing of mesalazine formulations
- (2015) Alvaro Goyanes et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Predicting the gastrointestinal behaviour of modified-release products: Utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers
- (2014) Hamid A. Merchant et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds
- (2013) Grzegorz Garbacz et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A novel coating concept for ileo-colonic drug targeting: Proof of concept in humans using scintigraphy
- (2013) F.J.O. Varum et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Long-term oral mesalazine adherence and the risk of disease flare in ulcerative colitis: nationwide 10-year retrospective cohort from the veterans affairs healthcare system
- (2012) N. Khan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ulcerative colitis
- (2012) Ingrid Ordás et al. LANCET
- Reproducibility of neutron activated Sm-153 oral dose formulations intended for human administration
- (2011) C.H. Yeong et al. APPLIED RADIATION AND ISOTOPES
- Oral modified-release formulations in motion: The relationship between gastrointestinal transit and drug absorption
- (2010) Felipe J.O. Varum et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract
- (2009) Fang Liu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A new concept in colonic drug targeting: a combined pH-responsive and bacterially-triggered drug delivery technology
- (2008) V. C. IBEKWE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man
- (2008) Emma L. McConnell et al. JOURNAL OF CONTROLLED RELEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now